Related Experiment Videos
[Silent myocardial ischemia in hypertensive patients]
Insights
Silent myocardial ischemia, common in hypertension, poses a significant risk. Detecting these silent events via ECG and blood pressure monitoring is crucial for better patient outcomes.
Area of Science:
- Cardiology
- Hypertension Research
- Ischemic Heart Disease
Context:
- Silent myocardial ischemia affects approximately 35% of hypertensive individuals.
- Ischemic events often occur without angina, remaining clinically silent.
- Standard exercise ECG may miss events detectable by 24-hour Holter monitoring.
Purpose:
- To highlight the prevalence and significance of silent myocardial ischemia in hypertensive patients.
- To emphasize the diagnostic value of simultaneous ECG and blood pressure monitoring.
- To underscore the prognostic implications of silent ischemia in hypertension.
Summary:
- Silent myocardial ischemia, triggered by hypertensive peaks or heart rate increases, is prevalent in hypertensive individuals.
- 24-hour Holter monitoring with simultaneous ST-triggered ECG and blood pressure recording is superior to exercise ECG for detecting silent ischemic events.
- Silent ischemia indicates a higher risk, potentially worse than known coronary artery disease (CAD) in hypertensive patients without CAD.
Impact:
- Objective ST-analysis of silent ischemia is vital for risk stratification in hypertensive patients.
- Identifying silent ischemia necessitates its inclusion in therapeutic strategies, primarily antihypertensive treatment.
- Effective management of silent ischemia can prevent adverse cardiovascular events and improve prognosis in hypertensive individuals.
Abstract:
Silent myocardial ischemia occurs in hypertensive individuals with a prevalence of approximately 35%. ST-alterations are triggered by a) hypertensive peaks and b) heart rate increase. Like in patients with coronary heart disease most ischemic events occur without angina. They are clinically silent. In daily practice silent myocardial ischemia may be detected by ECG under physical load or with 24 h Holter ECG-monitoring. The latter can detect ischemic events missed by ECG-monitored exercise tolerance. In hypertensive patients the simultaneous, ST-triggered recording of ECG and blood pressure data is more meaningful. Patients with silent ischemia are at higher risk than individuals without. Angor is not as strong a determinant of risk as silent ischemia. Hypertensive patients without coronary artery disease (CAD) who have silent ischemia may even have a worse prognosis than those with known CAD. It is therefore important to substantiate the objective extent of silent ischemia by ST-analysis. If detected it has to be included into therapeutic considerations with the goal to prevent such episodes by antihypertensive treatment.